Search results for "Pet imaging"

showing 5 items of 25 documents

A fully automatic method for biological target volume segmentation of brain metastases

2016

Leksell Gamma Knife is a mini-invasive technique to obtain a complete destruction of cerebral lesions delivering a single high dose radiation beam. Positron Emission Tomography (PET) imaging is increasingly utilized for radiation treatment planning. Nevertheless, lesion volume delineation in PET datasets is challenging because of the low spatial resolution and high noise level of PET images. Nowadays, the biological target volume (BTV) is manually contoured on PET studies. This procedure is time expensive and operator-dependent. In this article, a fully automatic algorithm for the BTV delineation based on random walks (RW) on graphs is proposed. The results are compared with the outcomes of…

gamma knifePET imagingcerebral tumors segmentation030218 nuclear medicine & medical imagingrandom walk03 medical and health sciences0302 clinical medicinemedicineSegmentationElectrical and Electronic EngineeringRadiation treatment planningCluster analysisImage resolution1707Settore ING-INF/05 - Sistemi Di Elaborazione Delle Informazionimedicine.diagnostic_testbusiness.industryElectronic Optical and Magnetic Materialbiological target volumePattern recognitionThresholdingElectronic Optical and Magnetic MaterialsRegion growingPositron emission tomography030220 oncology & carcinogenesisbiological target volume cerebral tumors segmentation gamma knife PET imaging random walkComputer Vision and Pattern RecognitionArtificial intelligenceNuclear medicinebusinessSoftwareVolume (compression)International Journal of Imaging Systems and Technology
researchProduct

An automatic method for metabolic evaluation of gamma knife treatments

2015

Lesion volume delineation of Positron Emission Tomography images is challenging because of the low spatial resolution and high noise level. Aim of this work is the development of an operator independent segmentation method of metabolic images. For this purpose, an algorithm for the biological tumor volume delineation based on random walks on graphs has been used. Twenty-four cerebral tumors are segmented to evaluate the functional follow-up after Gamma Knife radiotherapy treatment. Experimental results show that the segmentation algorithm is accurate and has real-time performance. In addition, it can reflect metabolic changes useful to evaluate radiotherapy response in treated patients.

medicine.diagnostic_testComputer sciencebusiness.industrymedicine.medical_treatmentComputer Science (all)PET imagingPattern recognitionLesion volumeRandom walkGamma knifeTheoretical Computer ScienceRadiation therapyBiological target volumeSegmentationBiological target volume Gamma Knife treatment PET imaging Random walk SegmentationPositron emission tomographymedicineSegmentationRadiotherapy treatmentGamma Knife treatmentArtificial intelligenceNoise levelbusinessImage resolution
researchProduct

Molecular imaging of gastroenteropancreatic neuroendocrine tumors.

2010

Somatostatin-receptor scintigraphy has become an obligatory molecular imaging method in the management of patients with neuroendocrine tumors when metastatic disease is suspected. Using positron emission tomography and new somatostatin analogues, sensitivity of somatostatin receptor imaging has further increased. With a combination of morphologic imaging methods, such as hybrid imaging by PET/CT, this method represents the method of choice in many centers and efforts are under way to translate somatostatin receptor imaging onto a cellular level by endoscopic confocal microscopy. Other clinically relevant functional pathways in neuroendocrine tumors that are accessible by PET imaging are glu…

medicine.medical_specialtyPathologyNeuroendocrine tumorsScintigraphylaw.inventionConfocal microscopylawmedicineHumansReceptors SomatostatinGastrointestinal NeoplasmsMicroscopy Confocalmedicine.diagnostic_testbusiness.industrySomatostatin receptorGastroenterologyPet imagingmedicine.diseaseCarcinoma NeuroendocrineMolecular ImagingPancreatic NeoplasmsNeuroendocrine TumorsSomatostatinPositron emission tomographyPositron-Emission TomographyRadiologyMolecular imagingRadiopharmaceuticalsbusinessGastroenterology clinics of North America
researchProduct

Radiolabeling of Nanoparticles and Polymers for PET Imaging

2014

Nanomedicine has become an emerging field in imaging and therapy of malignancies. Nanodimensional drug delivery systems have already been used in the clinic, as carriers for sensitive chemotherapeutics or highly toxic substances. In addition, those nanodimensional structures are further able to carry and deliver radionuclides. In the development process, non-invasive imaging by means of positron emission tomography (PET) represents an ideal tool for investigations of pharmacological profiles and to find the optimal nanodimensional architecture of the aimed-at drug delivery system. Furthermore, in a personalized therapy approach, molecular imaging modalities are essential for patient screeni…

radiolabelingmedicine.medical_specialtyPharmaceutical ScienceNanoparticlelcsh:Medicinelcsh:RS1-441NanotechnologyReviewlcsh:Pharmacy and materia medicaDrug DiscoverymedicineMedical physicsPersonalized therapypolymersmedicine.diagnostic_testbusiness.industrylcsh:RPositron emittersimagingPet imagingnanomedicinepositron emitterPETPositron emission tomographyDrug deliverydrug deliveryMolecular MedicineNanomedicinenanoparticlesMolecular imagingbusinessPharmaceuticals
researchProduct

Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT

2021

Despite the promising results of prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) in metastatic castration-resistant prostate cancer (mCRPC), some patients show worsening disease during PSMA-RLT. We investigated the value of combined [18F]FDG and [68Ga]Ga-PSMA-11 PET imaging in this setting. In n = 29 mCRPC patients with worsening disease after a median of four cycles of [177Lu]Lu-PSMA-617 RLT, combined [18F]FDG and [68Ga]Ga-PSMA-11 PET imaging was performed to detect [18F]FDG-avid lesions with low or no PSMA expression (mismatch lesions). To evaluate prognostic implication of mismatch, survival analyses regarding presence, location, and [18F]FDG PET-derived para…

radioligand therapy; PSMA; FDG; PET/CT; mismatch; metastatic castration-resistant prostate cancerCancer Researchmedicine.medical_specialtyFDGPET/CTUrology610Diseaseurologic and male genital diseasesMetastasisProstate cancerPSMAmedicineRC254-282Membrane antigenPET-CTbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensPet imagingMetabolic tumor volumemedicine.diseaseradioligand therapyTotal lesion glycolysismetastatic castration-resistant prostate cancerOncologybusinessmismatchCancers
researchProduct